GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (NAS:INCR) » Definitions » Long-Term Capital Lease Obligation

INCR (Intercure) Long-Term Capital Lease Obligation : $6.59 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Intercure Long-Term Capital Lease Obligation?

Intercure's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was $6.59 Mil.

Intercure's quarterly Long-Term Capital Lease Obligation declined from Dec. 2023 ($5.86 Mil) to Jun. 2024 ($5.04 Mil) but then increased from Jun. 2024 ($5.04 Mil) to Dec. 2024 ($6.59 Mil).

Intercure's annual Long-Term Capital Lease Obligation declined from Dec. 2022 ($6.56 Mil) to Dec. 2023 ($5.86 Mil) but then increased from Dec. 2023 ($5.86 Mil) to Dec. 2024 ($6.59 Mil).


Intercure Long-Term Capital Lease Obligation Historical Data

The historical data trend for Intercure's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure Long-Term Capital Lease Obligation Chart

Intercure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.99 6.07 6.56 5.86 6.59

Intercure Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Jun24 Dec24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.38 6.05 5.86 5.04 6.59

Intercure  (NAS:INCR) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Intercure Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Intercure's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Intercure Business Description

Industry
Traded in Other Exchanges
Address
85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.